Anthem In-House PBM Will Rely On CVS But Retain Formulary Control
Hybrid approach to pharmacy benefit management expected to save insurer $4bn annually after Anthem ends its relationship with Express Scripts in 2020. Plans include "going out to the market and competing with the freestanding PBMs."
You may also be interested in...
Data and intelligence will drive revolutionary changes in healthcare, and today's power brokers will need to adapt. Viren Mehta, founding partner of Mehta Partners LLC, considers how business consolidation in the complex US pharma market reflects the race to tap as yet under-exploited data troves, and how the resulting exploitation of those data may benefit a broader set of stakeholders.
Anthem wants out of contract – perhaps just to bring operations in-house.
With the acquisition of the largest plan-owned pharmacy benefit manager, Express Scripts will move to second place among the big stand-alone PBMs, ahead of CVS Caremark.